Management Team

TM 2

Chief Executive Officer

Thomas Meyer founded Auris Medical in April 2003 and was the Company's sole shareholder until the end of 2007. Prior to founding Auris Medical, he was the Chief Executive Officer of Disetronic Group, a leading Swiss supplier of precision infusion and injection systems. He worked for Disetronic in various functions starting in 1988, becoming member of  the Board of Directors in 1996, Deputy Chief Executive Officer in 1999 and Chief Executive Officer in early 2000. Prior to joining Disetronic, he advised several Swiss companies in strategy, marketing and corporate finance. Thomas Meyer served on the Board of Directors of several small and medium sized Swiss industrial companies; in some of them he was also a key investor. He holds a Ph.D. in business administration (Dr.rer.pol.) from the University of Fribourg, Switzerland.

abrHead of Regulatory and Quality Affairs

Andrea Braun has served as Auris Medical’s Head of Regulatory and Quality Affairs since May 2016 and leads the Company’s regulatory affairs, quality and pharmacovigilance activities. Prior to joining Auris Medical, Andrea was Head of Global Regulatory Affairs at Alvotech. Prior to Alvotech, she spent 15 years in various regulatory affairs functions at Roche, becoming Head of EU Regulatory Affairs in 2013, and five years in regulatory affairs at DSM Nutritional Products. Ms. Braun received her state examination in pharmacy from the University of Heidelberg, Germany, and holds a PhD in immunology from the University of Basel, Switzerland.

 

TJUChief Development Officer

Thomas Jung, MD, PhD, has served as Auris Medical’s Chief Development Officer since September 2016 and leads the Company's clinical, preclinical and pharmaceutical development activities. Prior to joining Auris Medical, Dr. Jung served as the Chief Medical Officer at Delenex Therapeutics AG and spent 13 years at Novartis, most recently as Head, Translational Medicine for the European Union. He is a board-certified dermatologist and is an Associate Professor for Dermatology at the University of Göttingen, Germany.

 

HLE

Chief Financial Officer

Hernan Levett, CPA, has served as Auris Medical’s Chief Financial Officer since January 2017. Prior to joining Auris Medical, Mr. Levett served as Head of Group Controlling at Acino Pharma AG and previously served as Vice President of Finance and Administration Europe at InterMune International AG. In addition, he spent 10 years at Novartis, most recently as Chief Financial Officer of Novartis Chile SA.

Sven ZimmermannGeneral Counsel

Anne Sabine Zoller joined us as Senior Legal Counsel in April 2015 and became Auris Medical’s General Counsel in August 2015. Prior to joining Auris Medical, Anne was a Corporate/M&A Counsel with Straumann Group, a dental implant company headquartered in Basel, and an attorney in the Corporate/M&A team of Homburger AG, a Zurich based law firm. She obtained a PhD in law from the University of Zurich and holds an MBA degree.